Upcoming Changes for Qualifying Gilead Prescriptions

‍

Due to efforts by many drug manufacturers to limit the access and scope of the 340B Drug Pricing Program, Second Sight Solutions has created a product named 340B ESP. This product has been created to gather additional claim level information in order to prevent duplicate discounts that they encounter. As a result, many manufacturers have partnered with Second Sight to allow them to collect this data on their behalf; thereby forcing the covered entities to provide this information or limit their contract pharmacy relationships to only one (or sometimes zero).

In an effort to comply with the new rules set forth by these various manufacturers, Pharmco will be partnering with Second Sight to streamline the process of getting this information over to the manufacturers so that you can continue to utilize our services for your patients.  We at Pharmco are dedicated to serving your patients and ensuring that you and them continue to have access to 340B pricing so that you can stretch scarce resources as much as possible.

‍